Use of Frozen Sections for the Pharmacological Characterization of Compounds Active on Neurotransmitter Receptors

References

• Goodman, Gilman's. The Pharmacological Basis of Therapeutics 9th ed. McGraw-Hill (Health Professions Division)., New York 1996
   Google Scholar
• Keen M., MacDermot J. Analysis of receptors by radioligand binding. Receptor Autoradiography Principles and Practice, J Wharton, J M Polak. Oxford University Press (Oxford Science Publications)., Oxford 1993
   Google Scholar
• Bennett J. P. Methods in binding studies. Neurotransmitter Receptor Binding, I H Yamamura, S J Enna, M J Kuhar. Raven Press, New York 1978
   Google Scholar
• Weiland G. A., Molinoff P. B. Quantitative Analysis of Drug-Receptor Interactions: I. Determination of Kinetic Equilibrium Properties. Life Sciences 1981; 29: 313–330
   PubMed Web of Science ®Google Scholar
• Ruffolo R. R. Review Important Concepts of Receptor Theory. J Auton Pharmacol 1982; 2: 277–295
   PubMedGoogle Scholar
• DeBlasi A., O'Reilly K, Motulsky H. J. Calculating Receptor Number from Binding Experiments Using Same Compound as Radioligand and Competitor. TIPS 1989; 10: 227–229
   PubMed Web of Science ®Google Scholar
• Gingrich J. A., Caron M. G. Recent Advances in the Molecular Biology of Dopamine Receptors. Annu Rev Neurosci 1993; 16: 299–321
   PubMed Web of Science ®Google Scholar
• Caulfield M. P. Muscarinic Receptors-Characterization, Coupling and Function. Pharmac Ther 1993; 58: 319–379
   PubMed Web of Science ®Google Scholar
• Mautner H. G. Receptor Theories and Dose-Response Relationships, The Basis of Medicinal Chemistry, Burger's Medicinal Chemistry Part I, 4th ed. John Wiley and Sons., New York 1980
   Google Scholar
• Wiliams, Lefkowitz. Receptor Binding Studies in Adrenergic Pharmacology. Raven Press, New York 1978
   Google Scholar
• Amenta F., Tayebati S. K., Piergentili A., Pigini M., Quaglia W., Sabbatini M., Giannella M. Sensitive Approach for the Pharmacological Characterization of Compounds Active on Neurotransmitter Receptors. 10th Camerino-Noordwijkerhout Symposium, Perspectives in Receptor Research, abstracts book. CamerinoItaly September 10–14, 1995
   Google Scholar
• Lowry O. H., Rosebruogh N. S., Farr A. L., Randdall R. J. Protein Measurement with the Folin Phenol Reagent. J Biol Chem 1951; 193: 265–268
   PubMed Web of Science ®Google Scholar
• Amenta F. Biochemistry and Autoradiography of Peripheral Dopamine Receptors. Peripheral Dopamine Pathophysiology, F. Amenta. CRC Press, Boca Raton 1990
   Google Scholar
• Amenta F., Gallo P., Rossodivita I., Ricci A. Radioligand Binding and Autoradiographic Analysis of Dopamine Receptors in the Human Heart. Naunyn Schmiedeberg's Arch Pharmacol 1993; 347: 147–154
   Google Scholar
• O'Malley K. L., Harmon S., Tang L., Todd R. D. The Rat Dopamine D4 Receptor: Sequence, and Demonstration of Expression in the Cardiovascular System. New Biologist 1992; 4: 137–146
   PubMedGoogle Scholar
• Cheng Y. C., Prusoff W. H. Relatinship Between the Inhibition Constant (Ki) and the Concentration of Inhibitor which Causes 50% Inhibition (IC50) of an Enzymatic Reaction. Biochem Pharmacol 1973; 22: 3099–3108
   PubMed Web of Science ®Google Scholar
• McPherson G. A., Molenaar P., Raper C., Malta E. Analysis of Dose-Response Curves and Calculation of Agonist Dissociation Constants Using a Weighted Nonlinear Curve Fitting Program. J Pharmacol Methods 1983; 10: 231–241
   PubMedGoogle Scholar
• Cooper J. R., Bloom F. E., Roth R. H. The Biochemical Basis of Neuropharmacology. University Press, Oxford New York 1982
   Google Scholar
• Flückiger E, Müller E. E., Thorner M. O. Basic and Clinical Aspects of Neuroscience. The Dopaminergic System. Berlin Heidelberg, Springer 1985
   Google Scholar
• Steriade M., Biesold D. Brain Cholinergic Systems. Oxford University Press, New York 1990
   Google Scholar
• Bonuccelli U., Rabey J. M. Old and New Dopamine Agonists in parkinson's Disease. J Neural Transmission Supplement 45. Springer-Verlag., New York 1995
   Google Scholar
• Witt-Enderby P. A., Yamamura H. I., Halonen M., Lai J., Palmer J. D., Bloom J. W. Regulation of Airway Muscarinic Cholinergic Receptor Subtypes by Chronic Anticholinergic Treatment. Mol Pharmacol 1995; 47: 485–490
   PubMed Web of Science ®Google Scholar
• Sibley D. R., Monsma F. J., Jr. Molecular Biology of Dopamine Receptors. Trends Pharmacol Sci 1992; 13: 61–69
   PubMed Web of Science ®Google Scholar
• Rabey J. M. Second Generation of Dopamine Agonists: Pros and Cons. J Neural Transm 1995; 45([Suppl.])213–245
   Google Scholar
• Hulme E. C., Birdsall J. M., Buckley N. J. Muscarinic Receptor Subtypes. Annu Rev Pharmacol Toxicol 1990; 30: 633–673
   PubMed Web of Science ®Google Scholar
• Fisher A., Haring R., Ginzburg I., Sadot E., Pittel Z., Barg Y., Behar L., Gurwitz D., Karton Y., Meshulam H., Marciano D., Brandeis R., Heldman E. Selective Signalling via New M1 Agonists: from Symptomatic Treatment towards Delaying the Progression of Alzheimer's Disease (AD). 3rd Symposium of Alzheimer's and Parkinson's Diseases, abstracts book, BresciaItaly, March, 7–91996
   Google Scholar
• Seeman P., Grigoriadis D. Dopamine Receptors in Brain and Periphery. Neurochem Int 1987; 10: 1–25
   PubMed Web of Science ®Google Scholar
• Lazareno S., Buckley N. J., Roberts F. F. Characterization of Muscarinic M4 Binding Sites in Rabbit Lung, Chicken Heart, and NG108-15 Cells. Mol Pharmacol 1990; 38: 805–815
   PubMed Web of Science ®Google Scholar
• Tobler H J., Engel G. Affinity Spectra: A Novel Way for the Evaluation of Equilibium Binding Experiments. Naunyn Schmied Arch Pharmacol 1983; 322: 183–192
   PubMed Web of Science ®Google Scholar
• Kuhar M. J. Background to Receptor Mapping and Future Trend. Receptor Autoradiography Principles and Practice, J Wharton, J M Polak. Oxford University Press, (Oxford Science Publications)., Oxford 1993
   Google Scholar